INHSU strongly supports the frameworks of the Sustainable Development Goals and the WHO commitments to eliminate hepatitis C by 2030.
We join the global calls by policy experts to ensure that the principles of universal access to health care, harm minimisation, and public health underpin approaches to drug user health and hepatitis C elimination. We also join with global partners in calls to increase financial commitments to eliminate hepatitis C.
Over the past decade, we have focused our work on bringing together evidence around hepatitis C treatment, care and support of people who use drugs. We now have a significant evidence-base about what works at a local, country and global level – knowledge which could prove vital in meeting the goal of elimination by 2030. We also have deep knowledge regarding the key issues and challenges that are hampering elimination efforts.
When developing policy and advocacy positions, we ensure that we:
- Engage with people who use drugs to ensure their experiences and perspectives are central to recommended actions and strategies
- Access information and knowledge around global directions and the work occurring within international multilateral organisational structures
- Locate the work to eliminate hepatitis C in the context of drug policy settings and a harm reduction approach
- Work with partners and stakeholders to ensure that it is accessing significant knowledge around the issues, challenges and opportunities at a country and regional level